查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
全球梅毒檢測市場 2023-2030
市場調查報告書
商品編碼
1327637

全球梅毒檢測市場 2023-2030

Global Syphilis Testing Market 2023-2030
出版日期: | 出版商: Orion Market Research | 英文 75 Pages | 商品交期: 2-3個工作天內

價格

預計全球梅毒檢測市場在預測期內（2023-2030）將以 6.2% 的年複合成長率成長。鈀密螺旋體是引起性傳播疾病梅毒的細菌。在前兩個階段，它的傳染性最強。梅毒的初始階段是隱性或潛伏階段，在​​此期間患者不會受到傷害。雖然沒有任何症狀，但疾病仍然存在。該疾病的第二階段，稱為三期梅毒，對健康危害最大。加速市場發展的一些主要促進因素包括性傳播感染（STD）患病率的上升、流產的增加以及醫療保健行業對高效疾病診斷和測試解決方案的需求不斷成長。因此，市場參與者在創建梅毒檢測產品和配套服務組合時將重點放在技術開發上，這將進一步支持市場擴張。例如，2023 年 2 月，為了應對大學校園性傳播感染的興起，Caraway 和 Ash Wellness 建立了合作夥伴關係。試劑盒中包含性傳播感染 (STI) 和性傳播感染 (STI) 檢測，例如衣原體、淋病、梅毒、愛滋病毒、丙型肝炎、滴蟲病、念珠菌病和細菌性陰道病。

細分市場前景

全球梅毒檢測市場根據檢測類型、地點、技術和最終用戶進行細分。根據類型，市場分為一期和二期梅毒以及潛伏和三期梅毒。根據檢測地點，市場可細分為實驗室檢測和即時護理 (POC) 檢測。此外，根據技術，市場細分為 CLIA、ELISA、NAAT 等。按最終用戶分類，市場分為醫院、診斷實驗室和家庭護理。

預計實驗室檢測細分市場將在全球梅毒檢測市場中佔據相當大的佔有率

在檢測地點中，實驗室檢測細分市場預計將在全球梅毒檢測市場中佔據相當大的佔有率。部分成長歸因於多种血清學檢測、快速血漿恢復（RPR）檢測和梅毒螺旋體顆粒凝集（TPPA）檢測的影響力不斷增強，以及實驗室檢測技術的進步和自動化系統的可用性提高了效率和周轉時間梅毒檢測時間。政府和醫療保健組織的醫療保健活動、教育計劃以及計劃都強調了梅毒檢測的重要性。根據美國國立衛生研究院 (NIH) 的說法，在活動性梅毒的情況下，非梅毒螺旋體檢測通常會呈陽性，並且會進行滴度測試。當後續血清學檢測顯示 VDRL 或 RPR 滴度呈陽性時，表明梅毒處於活動狀態，可用於追踪治療效果。例如，2023 年2 月，婦幼保健公司Maternova 與MedMira 建立了分銷合作夥伴關係，MedMira 是愛滋病毒、肝炎、梅毒等性傳播感染疾病快速診斷測試的創造者和製造商，總部位於加拿大新斯科舍省。

區域展望

全球梅毒檢測市場根據地理位置進一步細分，包括北美（美國和加拿大）、歐洲（英國、義大利、西班牙、德國、法國和歐洲其他地區）、亞太地區（印度、中國、日本） 、韓國和亞洲其他地區）以及世界其他地區（中東和非洲以及拉丁美洲）。其中，亞太地區預計將在全球市場中佔據顯著佔有率，因為不斷成長的醫療保健行業以及高效醫療保健基礎設施的建立。

北美地區預計全球梅毒檢測市場年複合成長率顯著成長

在所有地區中，預計北美在預測期內將以相當大的年複合成長率成長。北美，特別是美國，將繼續發揮不可忽視的關鍵作用。區域成長歸因於現代技術的廣泛使用以及該地區主要競爭對手的存在，這為市場參與者提供了多種擴張機會。例如，2023 年3 月，加拿大衛生部最近批准了一種HIV-梅毒雙重快速檢測，經過兩年的臨床試驗表明，該檢測在檢測HIV 感染方面的準確度為100%，在檢測活動性梅毒方面的準確度為98%。 DPP HIV-梅毒系統使性傳播疾病的快速檢測取得了令人興奮的進展。 DPP HIV-梅毒系統目前可供美國超過 200,000 個 CLIA 豁免的即時檢測機構使用。推動市場成長的另一個因素是MSM（男男性行為）病例的增加以及對孕婦進行篩查測試的要求。

市場參與者展望

服務於梅毒檢測市場的主要公司包括： Abbott 實驗室、Bio-Rad 實驗室公司、F. Hoffmann-La Roche AG、Thermo Fisher Scientific Inc.、Hologoic Inc. 等。通過使用各種技術，包括併購、夥伴關係、合作、融資和新產品的推出，該行業的公司正在顯著促進市場成長。例如，2023 年 3 月，加拿大衛生部授權 bioLytical Laboratory Inc. 進行 INSTI (R) Multiplex HIV-1/2 梅毒抗體檢測。該測試通過僅使用一份樣本提供兩種感染的結果，使醫生能夠在更短的時間內測試更多的人，從而減輕患者的測試焦慮。

報告涵蓋：

  • 2022年市場價值數據分析及2030年預測。
  • 每個細分市場的年化市場收入（百萬美元）。
  • 主要地理區域的國家分析。
  • 全球梅毒檢測市場的主要公司。根據現有數據，報告中還提供了與新產品發布相關的資訊以及相關新聞。
  • 通過確定未來強勁成長的關鍵細分市場來分析業務戰略。
  • 市場進入和市場擴張策略分析。
  • 通過識別市場中“誰的立場”來製定競爭策略。

目錄

第 1 章：報告摘要

  • 當前行業分析及成長潛力展望
  • 研究方法和工具
  • 市場細分
    • 按細分
    • 按地區

第 2 章：市場概述和見解

  • 報告範圍
  • 分析師見解和當前市場趨勢
    • 主要發現
    • 建議
    • 結論

第 3 章：競爭格局

  • 主要公司分析
  • Abbott Laboratories
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Becton Dickinson and Co.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • Bio-Rad Laboratories Inc.
    • 概述
    • 財務分析
    • SWOT分析
    • 最近的發展
  • 關鍵策略分析

第 4 章：市場細分

  • 按類型分類的全球梅毒檢測市場
    • 一期和二期梅毒
    • 潛伏梅毒和三期梅毒
  • 按檢測地點分類的全球梅毒檢測市場
    • 實驗室測試
    • 即時護理 (POC) 測試
  • 按技術分類的全球梅毒檢測市場
    • 臨床實驗室改進修正案 (CLIA)
    • 酶聯免疫吸附測定 (ELISA)
    • 核酸擴增測試（NAAT）
    • 其他
  • 按最終用戶分類的全球梅毒檢測市場
    • 醫院
    • 診斷測試
    • 家庭護理

第 5 章：區域分析

  • 北美
    • 美國
    • 加拿大
  • 歐洲
    • 英國
    • 德國
    • 義大利
    • 西班牙
    • 法國
    • 歐洲其他地區
  • 亞太
    • 中國
    • 印度
    • 日本
    • 韓國
    • 亞太其他地區
  • 世界其他地區

第 6 章：公司簡介

  • Astam Dignostic
  • Beckman Coulter
  • bioLytical laboratories Inc.
  • BioMerieux SA
  • Cepheid Inc.
  • Danaher corp.
  • Diasorin S.P.A
  • DRG International Inc. (BioCheck Inc.)
  • F. Hoffmann-La Roche AG
  • Fujirebio
  • Hologoic Inc
  • Omega diagnostics Group PLC
  • Shenzhen new industries Biomedical Engineering Co., Ltd.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
Product Code: OMR2027544

Title: Global Syphilis Testing Market Size, Share & Trends Analysis Report by Type (Primary and Secondary Syphilis, Latent and Tertiary Syphilis), by Location of Testing (Laboratory Testing, Point-of-Care (POC) Testing), and by Technology (Clinical Laboratory Improvement Amendments (CLIA), Enzyme-Linked Immunosorbent Assay (ELISA), Nucleic Acid Amplification Test (NAAT), and Others), by End User (Hospitals, Diagnostic Labs, Home Care),Forecast Period (2023-2030).

The global syphilis testing market is anticipated to grow at a CAGR of 6.2% during the forecast period (2023-2030). Treponema palladium is the bacterium that causes the sexually transmitted disease syphilis. During the first two phases, it is most contagious. The initial stage of syphilis is the concealed, or latent, stage, during which the patient is not harmed. Although there are no symptoms, the disease is still vital. The second stage of the disease, referred to as tertiary syphilis, is the most harmful to health. Some main driving factor that accelerating the market include the rising prevalence of sexually transmitted infections (STDs), the rise in miscarriages, and the rising demand for efficient disease diagnostic and testing solutions in the healthcare industry. As a result, market participants are concentrating on technology developments when creating syphilis testing products and accompanying service portfolios, which will further support market expansion. For Instance, In February 2023, to combat the rise of STIs on college campuses, Caraway and Ash Wellness started a partnership. tests for STIs and sexually transmitted infections (STIs), such as chlamydia, gonorrhea, syphilis, HIV, hepatitis C, trichomoniasis, candidiasis, and bacterial vaginosis, are included in the kits.

Segmental Outlook

The global syphilis testing market is segmented on the type, location of testing, technology, and end-users. Based on the type, the market is sub-segmented into primary & secondary syphilis and latent & tertiary syphilis. Based on the location of testing, the market is sub-segmented laboratory testing and point-of-care (POC) testing. Further, on the basis of technology, the market is sub-segmented into CLIA, ELISA, NAATs, and others. By end-user, the market is sub-segmented into hospitals, diagnostic labs, and home care.

The Laboratory Testing Sub-Segment is Anticipated to Hold a Considerable Share of the Global Syphilis Testing Market

Among the location of testing, the laboratory testing sub-segment is expected to hold a considerable share of the global syphilis testing market. The segmental growth is attributed to the growing influence of several serological tests, rapid plasma regain (RPR) test, and Treponema pallidum particle agglutination (TPPA) test, and advancements in laboratory testing technologies and the availability of automated systems have improved the efficiency and turnaround time of syphilis testing. Healthcare campaigns, educational programs, and initiatives by governments and healthcare organizations have emphasized the significance of syphilis testing. According to the National Institute of Health (NIH), The nontreponemal test will typically be positive in situations of active syphilis, and a titter will be carried out. When a follow-up serologic test reveals a positive titter with a VDRL or RPR, it indicates that syphilis is active, and it is used to track treatment effectiveness. For instance, in February 2023, the maternal and child health company Maternova established a distribution partnership with MedMira, a creator and manufacturer of quick diagnostic tests for STIs diseases like HIV, hepatitis, syphilis, and others with headquarters in Nova Scotia, Canada.

Regional Outlook

The global syphilis testing market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America. Among these, the Asia-Pacific region is anticipated to hold a prominent share of the market across the globe, owing to the continuously growing healthcare industry coupled with rise in establishment of efficient healthcare infrastructure.

The North America Region is Expected to Grow at a Significant CAGR in the Global Syphilis Testing Market

Among all regions, North America is anticipated to grow at a considerable CAGR over the forecast period. North America, and particularly the US, will continue to play a crucial role that cannot be disregarded. The regional growth is attributed to the widespread use of modern technologies and the presence of major competitors in the region, which offers several opportunities of expansion for market players. For instance, in March 2023, a dual HIV-syphilis fast test was recently approved by Health Canada after a two-year clinical trial revealed that it was 100% accurate at detecting HIV infections and 98% accurate in detecting active syphilis. Rapid testing for sexually transmitted illnesses has excitingly advanced with the DPP HIV-Syphilis System. The DPP HIV-Syphilis System is currently available to more than 200,000 CLIA-waived point-of-care testing facilities in the US. Another factor bolstering the market growth is owing to the rising MSM (men having sex with men) cases along with the implementation of screening tests as a requirement for pregnant women.

Market Players Outlook

The major companies serving the syphilis testing market include: Abbott laboratories, Bio-Rad laboratories Inc., F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Hologoic Inc. and others. By using a variety of techniques, including as mergers and acquisitions, partnerships, collaborations, funding, and the launch of new products, companies in the industry are significantly boosting market growth. For instance, in March 2023 Health Canada grants authorization to bioLytical laboratories Inc. for its INSTI® Multiplex HIV-1/2 syphilis antibody test. The test lessens test anxiety for patients by enabling medical practitioners to test more people in less time by providing results for two infections with just one sample.

The Report Covers:

  • Market value data analysis of 2022 and forecast to 2030.
  • Annualized market revenues ($ million) for each market segment.
  • Country-wise analysis of major geographical regions.
  • Key companies operating in the global syphilis testing market. Based on the availability of data, information related to new product launches, and relevant news is also available in the report.
  • Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
  • Analysis of market-entry and market expansion strategies.
  • Competitive strategies by identifying 'who-stands-where' in the market.

Table of Contents

1. Report Summary

  • Current Industry Analysis and Growth Potential Outlook
  • 1.1. Research Methods and Tools
  • 1.2. Market Breakdown
    • 1.2.1. By Segments
    • 1.2.2. By Region

2. Market Overview and Insights

  • 2.1. Scope of the Report
  • 2.2. Analyst Insight & Current Market Trends
    • 2.2.1. Key Findings
    • 2.2.2. Recommendations
    • 2.2.3. Conclusion

3. Competitive Landscape

  • 3.1. Key Company Analysis
  • 3.2. Abbott Laboratories
    • 3.2.1. Overview
    • 3.2.2. Financial Analysis
    • 3.2.3. SWOT Analysis
    • 3.2.4. Recent Developments
  • 3.3. Becton Dickinson and Co.
    • 3.3.1. Overview
    • 3.3.2. Financial Analysis
    • 3.3.3. SWOT Analysis
    • 3.3.4. Recent Developments
  • 3.4. Bio-Rad Laboratories Inc.
    • 3.4.1. Overview
    • 3.4.2. Financial Analysis
    • 3.4.3. SWOT Analysis
    • 3.4.4. Recent Developments
  • 3.5. Key Strategy Analysis

4. Market Segmentation

  • 4.1. Global Syphilis Testing Market by Type
    • 4.1.1. Primary and secondary Syphilis
    • 4.1.2. Latent and Tertiary Syphilis
  • 4.2. Global Syphilis Testing Market by Location of Testing
    • 4.2.1. Laboratory Testing
    • 4.2.2. Point-of-Care (POC) Testing
  • 4.3. Global Syphilis Testing Market by Technology
    • 4.3.1. Clinical Laboratory Improvement Amendments (CLIA)
    • 4.3.2. Enzyme-Linked Immunosorbent Assay (ELISA)
    • 4.3.3. Nucleic Acid Amplification Test (NAAT)
    • 4.3.4. Others
  • 4.4. Global Syphilis Testing Market by End User
    • 4.4.1. Hospitals
    • 4.4.2. Diagnostic Test
    • 4.4.3. Home Care

5. Regional Analysis

  • 5.1. North America
    • 5.1.1. United States
    • 5.1.2. Canada
  • 5.2. Europe
    • 5.2.1. UK
    • 5.2.2. Germany
    • 5.2.3. Italy
    • 5.2.4. Spain
    • 5.2.5. France
    • 5.2.6. Rest of Europe
  • 5.3. Asia-Pacific
    • 5.3.1. China
    • 5.3.2. India
    • 5.3.3. Japan
    • 5.3.4. South Korea
    • 5.3.5. Rest of Asia-Pacific
  • 5.4. Rest of the World

6. Company Profiles

  • 6.1. Astam Dignostic
  • 6.2. Beckman Coulter
  • 6.3. bioLytical laboratories Inc.
  • 6.4. BioMerieux SA
  • 6.5. Cepheid Inc.
  • 6.6. Danaher corp.
  • 6.7. Diasorin S.P.A
  • 6.8. DRG International Inc. (BioCheck Inc.)
  • 6.9. F. Hoffmann-La Roche AG
  • 6.10. Fujirebio
  • 6.11. Hologoic Inc
  • 6.12. Omega diagnostics Group PLC
  • 6.13. Shenzhen new industries Biomedical Engineering Co., Ltd.
  • 6.14. Siemens Healthineers AG
  • 6.15. Thermo Fisher Scientific Inc.

LIST OF TABLES

  • 1. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 2. GLOBAL PRIMARY AND SECONDARY SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 3. GLOBAL LATENT AND TERTIARY SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 4. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 5. GLOBAL SYPHILIS TESTING IN LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 6. GLOBAL SYPHILIS TESTING IN POINT-OF-CARE (POC) MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 7. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 8. GLOBAL CLIA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 9. GLOBAL ELISA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 10. GLOBAL NAATS-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 11. GLOBAL OTHER TECHNOLOGIES BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 12. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END USER, 2022-2030 ($ MILLION)
  • 13. GLOBAL SYPHILIS TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 14. GLOBAL SYPHILIS TESTING IN DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 15. GLOBAL SYPHILIS TESTING IN HOME-CARE MARKET RESEARCH AND ANALYSIS 2022-2030 ($ MILLION)
  • 16. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022-2030 ($ MILLION)
  • 17. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 18. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 19. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 20. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 21. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 22. NORTH AMERICAN SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2022-2030 ($ MILLION)
  • 23. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 24. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 25. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 26. EUROPE SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 27. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE 2022-2030 ($ MILLION)
  • 28. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 29. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 30. ASIA-PACIFIC SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TYPE, 2022-2030 ($ MILLION)
  • 32. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022-2030 ($ MILLION)
  • 33. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022-2030 ($ MILLION)
  • 34. REST OF THE WORLD SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022-2030 ($ MILLION)

LIST OF FIGURES

  • 1. GLOBAL SYPHILIS TESTING MARKET SHARE BY TYPE, 2022 VS 2030 (%)
  • 2. GLOBAL PRIMARY AND SECONDARY SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 3. GLOBAL LATENT AND TERTIARY SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 4. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY LOCATION OF TESTING, 2022 VS 2030 (%)
  • 5. GLOBAL SYPHILIS TESTING IN LABORATORY MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 6. GLOBAL SYPHILIS TESTING IN POINT-OF-CARE (POC)MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 7. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 8. GLOBAL CLIA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 9. GLOBAL ELISA-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 10. GLOBAL NAATS-BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 11. GLOBAL OTHER TECHNOLOGIES BASED SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY TECHNOLOGY, 2022 VS 2030 (%)
  • 12. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY END-USER, 2022 VS 2030 (%)
  • 13. GLOBAL SYPHILIS TESTING IN HOSPITALS MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 14. GLOBAL SYPHILIS TESTING IN DIAGNOSTIC LABS MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 15. GLOBAL SYPHILIS TESTING IN HOME-CARE MARKET RESEARCH AND ANALYSIS, 2022 VS 2030 (%)
  • 16. GLOBAL SYPHILIS TESTING MARKET RESEARCH AND ANALYSIS BY REGION, 2022 VS 2030 (%)
  • 17. GLOBAL SYPHILIS TESTING MARKET SHARE BY REGION, 2022 VS 2030 (%)
  • 18. US SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 19. CANADA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 20. UK SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 21. FRANCE SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 22. GERMANY SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 23. ITALY SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 24. SPAIN SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 25. REST OF EUROPE SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 26. INDIA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 27. CHINA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 28. JAPAN SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 29. SOUTH KOREA SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 30. REST OF ASIA-PACIFIC SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)
  • 31. REST OF THE WORLD SYPHILIS TESTING MARKET SIZE, 2022-2030 ($ MILLION)